Genetic Technologies Appoints Mark Ziirsen As Chief Financial Officer
Portfolio Pulse from Benzinga Newsdesk
Genetic Technologies Limited (NASDAQ: GENE) has appointed Mark Ziirsen as its new Chief Financial Officer and Company Secretary. Ziirsen brings over 25 years of experience in finance leadership roles across various industries, including life sciences and technology.

July 16, 2024 | 12:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Genetic Technologies Limited has appointed Mark Ziirsen as its new CFO and Company Secretary. Ziirsen's extensive experience in finance leadership roles is expected to positively impact the company's financial strategy and operations.
The appointment of a highly experienced CFO like Mark Ziirsen is likely to enhance the company's financial strategy and operations. His background in supporting technology-driven businesses and raising capital could be particularly beneficial for Genetic Technologies Limited.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100